Principal indications for nuclear cardiology
| Notes | |
| Assessment of coronary artery disease, ischaemia and viability using myocardial perfusion scintigraphy/positron emission tomograph. | |
| Assessment of left ventricular function in undergoing cardiotoxic cancer therapy (baseline and serial) where echocardiography is not appropriate using multigated acquisition/radionuclide ventriculography. | |
| Investigating Infective endocarditis in special circumstances (eg, uncertainty-based around Duke criteria/indwelling medical devices).73 | ESC 2015 73 |
| Myocardial inflammation (especially sarcoidosis) using positron emission tomography. | |
| Transthyretin-type cardiac amyloidosis using bone scintigraphy (particularly with 99mTc-DPD).74 | ESC 2014 74 |
DPD, deoxypyridinoline; ESC, European Society of Cardiology.